Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Urology|March 27, 2003
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trialWayne J G Hellstrom, Marc Gittelman, Gary Karlin, et al.
Research and Reports in Urology|September 8, 2016
Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studiesAaron Spitz, Marc Gittelman, Lawrence I Karsh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 23, 2017
EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISMGlenn Cunningham, Laurence Belkoff, Gerald Brock, et al.
Urology Practice|June 15, 2023
An Actual Use Study of Tamsulosin in Men with Bothersome Urinary Symptoms in a Simulated Over-the-Counter SettingClaus G Roehrborn, Franklin C Lowe, Marc Gittelman, et al.
Journal of Psychosomatic Obstetrics and Gynaecology|June 7, 2006
Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: in-clinic evaluation of safety and efficacyJulia R Heiman, Marc Gittelman, Raymond Costabile, et al.
The Journal of Urology|March 12, 2003
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitisJ Curtis Nickel, Michel Pontari, Timothy Moon, et al.
European Urology|October 20, 2007
An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month studyWayne J G Hellstrom, Marc Gittelman, Jonathan Jarow, et al.
The Journal of Sexual Medicine|October 22, 2022
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and SafetyStanton Honig, Marc Gittelman, Jed Kaminetsky, et al.
European Urology|July 6, 2006
Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled studyHartmut Porst, Ira D Sharlip, Dimitris Hatzichristou, et al.
Pageof 3